Ajo LP Buys Shares of 110,778 Luminex Corp. (LMNX)
Ajo LP bought a new stake in Luminex Corp. (NASDAQ:LMNX) during the second quarter, Holdings Channel reports. The institutional investor bought 110,778 shares of the company’s stock, valued at approximately $2,241,000. Ajo LP owned approximately 0.25% of Luminex Corp. at the end of the most recent quarter.
A number of other hedge funds and other institutional investors also recently modified their holdings of LMNX. BlackRock Fund Advisors increased its position in shares of Luminex Corp. by 1.6% in the first quarter. BlackRock Fund Advisors now owns 3,017,364 shares of the company’s stock valued at $58,537,000 after buying an additional 46,200 shares in the last quarter. Prudential Financial Inc. increased its position in shares of Luminex Corp. by 5.3% in the first quarter. Prudential Financial Inc. now owns 93,840 shares of the company’s stock valued at $1,820,000 after buying an additional 4,700 shares in the last quarter. Aperio Group LLC increased its position in shares of Luminex Corp. by 36.6% in the first quarter. Aperio Group LLC now owns 13,048 shares of the company’s stock valued at $253,000 after buying an additional 3,499 shares in the last quarter. Renaissance Technologies LLC increased its position in shares of Luminex Corp. by 19.1% in the first quarter. Renaissance Technologies LLC now owns 1,007,840 shares of the company’s stock valued at $19,552,000 after buying an additional 161,800 shares in the last quarter. Finally, BlackRock Group LTD increased its position in shares of Luminex Corp. by 4.6% in the first quarter. BlackRock Group LTD now owns 64,271 shares of the company’s stock valued at $1,247,000 after buying an additional 2,828 shares in the last quarter. Institutional investors and hedge funds own 80.50% of the company’s stock.
Shares of Luminex Corp. (NASDAQ:LMNX) traded up 0.18% during trading on Monday, hitting $21.90. The company had a trading volume of 42,370 shares. Luminex Corp. has a 52 week low of $16.16 and a 52 week high of $23.75. The firm’s 50 day moving average is $21.54 and its 200-day moving average is $20.50. The stock has a market capitalization of $953.70 million, a P/E ratio of 22.86 and a beta of 0.45.
Luminex Corp. (NASDAQ:LMNX) last posted its quarterly earnings data on Thursday, July 28th. The company reported $0.33 EPS for the quarter, beating analysts’ consensus estimates of $0.15 by $0.18. The company earned $64.20 million during the quarter, compared to analysts’ expectations of $61.20 million. Luminex Corp. had a return on equity of 13.65% and a net margin of 16.60%. Luminex Corp.’s revenue for the quarter was up 8.9% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.27 earnings per share. Equities research analysts anticipate that Luminex Corp. will post $0.63 EPS for the current fiscal year.
Several analysts have weighed in on the company. Zacks Investment Research cut Luminex Corp. from a “buy” rating to a “hold” rating in a report on Monday, July 4th. JPMorgan Chase & Co. raised Luminex Corp. from an “underweight” rating to a “neutral” rating and raised their price target for the company from $18.00 to $22.00 in a report on Thursday, August 18th. Finally, Jefferies Group raised their price target on Luminex Corp. from $21.00 to $23.00 and gave the company a “hold” rating in a report on Thursday, July 28th. Six investment analysts have rated the stock with a hold rating, The stock has a consensus rating of “Hold” and a consensus price target of $22.20.
About Luminex Corp.
Luminex Corporation develops, manufactures and sells biological testing technologies with applications throughout the diagnostics, pharmaceutical and life sciences industries. The Company has a range of instruments using its xMAP technology, including its LUMINEX 100/200 systems offer 100-plex testing; the Company’s FLEXMAP 3D system is its high-throughput, 500-plex testing system, and its MAGPIX system provides 50-plex testing using imaging rather than flow cytometry.
Want to see what other hedge funds are holding LMNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Luminex Corp. (NASDAQ:LMNX).
Receive News & Ratings for Luminex Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Luminex Corp. and related companies with Analyst Ratings Network's FREE daily email newsletter.